Results revealed that thymol (15) effectively reduced the symptoms of allergic asthma through dose-dependent inhibition of IL-4, IL-5 and IL-13 production at 4, 8 and 16 mg/kg in OVA-challenged mice. Here, IL5 is linked to allergic asthma.